January 2016

The Innovation Spark Catches Fire

August 1, 2016

Medical innovation can help patients live longer, healthier, and more productive lives. Innovative medicines developed by America’s biopharmaceutical research companies have helped increase childhood cancer survival rates from 58% in 1970 to 83% today and have contributed to declining death rates for patients battling diseases such as HIV/AIDS (85% decline since 1995), heart disease (30% […]

Letter from the Editor

January 1, 2016

The Year Ahead Last month we identified 10 mega-trends that we, as well as others, think will impact the industry going forward. One of these trends is the increasing focus on the brain and the research efforts ongoing to understand the mysteries of this three-pound organ. And while scientists have learned more about the brain […]

UpFront

January 1, 2016

Industry at Large Helping Kids with Asthma Medikidz and Meda Pharmaceuticals have launched Explain Asthma, a comic book series launched in conjunction with the American College of Asthma, Allergy, and Immunology (ACAAI). The series is designed to help families gain an accurate understanding of asthma, and to support communication between experts and patients/families. Explain Asthma […]

Innovator’s Corner

January 1, 2016

Modifying the Immune System for Those with Food Allergies DBV Technologies’ CEO and Co-founder Pierre-Henri Benhamou talks about his company’s development of a patch for peanut and other food allergies. The prevalence of food allergies appears to be on the rise. While there is no cure for food allergies, traditional treatment approaches involve desensitization, which […]

mHealth

January 1, 2016

Quintiles Contributes Open Source Code to ResearchKit  Trending Now: Enhancements enable patient engagement tools for ResearchKit-based apps. Quintiles has contributed enhancements to the ResearchKit framework that provide developers with extensions that support additional capabilities, which, in turn, will allow them to create more sophisticated application experiences. Quintiles plans to use these enhancements to develop patient […]

What’s New

January 1, 2016

New Agency Brand Architecture  Trending now:  Publicis Health Media launches new model across its three U.S. hubs. Publicis Health Media (PHM) has launched a new branding architecture, affecting its three key office locations in Philadelphia, New York, and Chicago. The strategic branding restructure was developed as a result of the company’s rapid growth, its growing […]

Pharma Trax

January 1, 2016

Adverse Drug Event Reporting in U.S. Plagued by Incompleteness and Inaccuracy Trending now: A high proportion of healthcare professionals have no ADE reporting experience. Voluntary adverse drug event (ADE) reporting in the United States is incomplete, inaccurate, and inefficient, which could deny or limit patient access to safe and effective treatments, according to recent studies […]

Tools of the Trade

January 1, 2016

PerkinElmer Launches Signals for Translational    Trending Now:  New cloud-based informatics platform supports complete precision medicine workflow. PerkinElmer has launched PerkinElmer Signals for Translational, a cloud-based data management, aggregation, and analysis platform for pharmaceutical researchers. This new offering integrates experimental and clinical research data from many sources and relates the data to scientifically meaningful concepts. […]

The Calendar

January 1, 2016

Coming Attractions The 7th Annual SCOPE Summit, Feb. 23-25, 2016, Miami, offers three stimulating days of in-depth discussions in 12 different conferences, four pre-conference workshops, and two symposia focused on issues related to each aspect of clinical trial planning and management: data integration, feasibility, site selection and management, patient engagement, recruitment and retention, mobile tech, […]

Talent Pool

January 1, 2016

Pharma pool Paul Biondi Bristol-Myers Squibb Appoints Senior VP, Head of Business Development Bristol-Myers Squibb has appointed Paul Biondi as senior VP, head of business development. In this role, he is responsible for leading the development of strategic partnerships and pursuing scientific innovations across commercial, development, discovery, and technology platforms.  Mr. Biondi most recently served […]

Last Word

January 1, 2016

Filling Unmet Needs for Patients David Meek, Executive VP and President, Oncology, Baxalta, talks about how pharmaceutical companies can bridge the research gap in areas of high unmet need. PV: What do you think is needed to translate scientific advances into real benefits for patients? Meek: Collaboration is essential. It is our duty as an […]

The Brain: The Decade Ahead

January 1, 2016

The three-pound organ — made up of more than 100 billion nerves — that serves as the center of the nervous system is one of the most complex parts of the human body. Only recently have researchers and scientists begun to understand the brain and what can go wrong. This special forum kicks off a […]

Sales Reps: A Changing Conversation

January 1, 2016

There are few sectors that have experienced more upheaval than pharmaceutical sales, with Food & Drug Administration rules, evolving healthcare policies, and the movement of many healthcare practitioners from private, independent offices to group practices all contributing to an increasingly challenging sales process, so say the experts at Illuminate. Most in the industry can agree […]

Advertising Agency Hot Topics

January 1, 2016

In late 2015, the American Medical Association called for a ban on DTC advertising of prescription drugs and medical devices, drawing the conclusion that the billions of advertising dollars being spent to promote prescription products was helping to inflate the cost of prescription drugs. Physicians cited concerns that a growing proliferation of ads is driving […]

Beyond Pricing: What Payers Want

January 1, 2016

Value-assessment mechanisms, comparative effectiveness, and health economics and outcomes research are among several factors that are forcing the life-sciences industry to better illustrate the overall value of its products in an attempt to retain some power over insurance reimbursement decisions. As pharmaceutical and biotechnology companies prepare to enter tomorrow’s market, now more than ever, they […]

Pharma R&D is Now Biomarker-Driven

January 1, 2016

Biomarkers are becoming an essential part of the drug discovery and development process. A biomarker-driven approach to developing targeted therapies and patient selection strategies has the potential to increase success in the drug development process, decrease costs, and ultimately improve patient outcomes. The Tufts Center for the Study of Drug Development estimates the cost of […]

Despite Turbulence, Brazil Remains A Priority Market

January 1, 2016

A BRIC nation and the largest economy in South America, Brazil is regarded by most industries as a key market. Starting in the mid-1990s the country entered a period of economic stabilization, followed by strong growth in the early 2000s, driven by the commodities sector. In addition, Brazil experienced significant population growth two to three decades […]

SHOWCASE FEATURE: Social Anxiety

January 1, 2016

Of the 50 largest pharmaceutical companies worldwide, according to a study by the IMS Institute for Healthcare Informatics, only half are even dabbling in social media. Furthermore, only 10 of these companies are using the big three — Facebook, Twitter, and YouTube — and an even smaller number are interacting with patients in a meaningful […]

Hey, Pharma! The Social Train Has Left! Get on the Bus!

January 1, 2016

Pharma! Time to stop waiting for the long-anticipated social media guidance from the FDA and procrastinating on developing a social brand footprint. Social media is now part of the cost of entry in connecting with your customers. Consumers expect — and are accustomed to — brands being present on the major social platforms and look […]

Becoming Peers With Professionals On Social Networks

January 1, 2016

The ecosystem of social networks for healthcare professionals is incredibly diverse. For an increasing number of physicians in the United States, there is no epicenter for online dialogue like Facebook, nor a network with the meteoric growth of SnapChat or Instagram. What is happening is a quickly maturing and a highly specialized web of social […]

Reaching Hard-to-Reach Healthcare Professionals: Engage In On-line Communities

January 1, 2016

Prescribers, pharmacists, and medical directors all have an ongoing need for information on the latest advances in their respective fields. Yet, it is increasingly difficult for life sciences to deliver product information via in-person rep visits; in fact, many busy professionals have a policy against seeing industry sales reps making them hard to reach.  Within […]

FEEDBACK